DoD Prostate Cancer Idea Development Award | Apply Online

Opportunity Summary:

The DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a long-running Department of the Army funding mechanism meant to push genuinely new, high-impact ideas in prostate cancer research. First offered in FY97, it has attracted a large national pool of proposals (6,297 applications received) with a subset advancing to funding recommendations (1,097 recommended). The central purpose of the award is to back innovative concepts that could meaningfully advance the PCRP mission, even when the work carries some scientific risk. That risk tolerance is not a blank check, though; proposals still need a solid scientific rationale grounded in logical reasoning and/or a careful, critical reading of the existing literature.

A defining feature of this opportunity is its strict emphasis on innovation rather than incremental progress. Competitive applications are expected to introduce a new paradigm, challenge prevailing assumptions, reframe an old problem in an original way, or otherwise demonstrate clear creativity. Projects that mainly extend already-published findings in a straightforward, stepwise fashion are specifically called out as not meeting the innovation bar. Preliminary data are encouraged because they can strengthen credibility and feasibility, but they are not required, reflecting the program’s intent to give space to bold concepts that may be too early for traditional, data-heavy grant mechanisms.

The solicitation is intentionally broad in who it aims to attract. The PCRP encourages proposals from a wide range of disciplines, including basic science and translational work, clinical research, engineering, bioinformatics, population science, and psycho-oncology, among others. Regardless of discipline, applicants are expected to align their project with at least one PCRP focus area, and they are strongly encouraged to address one of the program’s overarching challenges. If a proposal does not map directly onto an overarching challenge, the application is expected to make a clear case for why the work still addresses an urgent and important unmet need in prostate cancer research and/or patient care.

Impact is another major review theme. The award stresses both short-term and long-term potential to influence the field, whether by opening a new research direction, enabling downstream translational steps, or improving patient-relevant outcomes. To strengthen the likelihood of real-world relevance, applicants are strongly encouraged (where appropriate) to build in research practices that have become key markers of quality and reproducibility in biomedical science. The announcement highlights three in particular: authentication of proposed cell lines, statistical rigor in preclinical animal studies, and inclusion of experiments that test clinical relevance and translatability of findings.

To support clinically meaningful work, the PCRP points applicants toward established resources that can accelerate discovery and strengthen human relevance. If a project depends on retrospectively collected human biospecimens or linked datasets, applicants are encouraged to consider using the PCRP-funded Prostate Cancer Biorepository Network (PCBN) and/or the North Carolina-Louisiana Prostate Cancer Project (PCaP). More broadly, the opportunity also welcomes studies that leverage large patient datasets with long-term health records and biospecimen repositories, especially when paired with modern genomic or proteomic methods, bioinformatics, and/or mathematical modeling. This signals an interest in proposals that can connect molecular findings to patient trajectories and outcomes using contemporary data-driven approaches.

The FY15 version of the award includes two notable participation structures aimed at shaping who applies and how teams are built. First, a New Investigator category is designed to help early-career faculty and researchers building independence compete in a separate pool from more established investigators. New Investigators are strongly encouraged to collaborate with experienced prostate cancer researchers or others with complementary expertise and strong track records, and the application is expected to explain how those collaborations fill gaps and strengthen the project. There are specific eligibility rules for this category, and an important limitation: New Investigators cannot use the Partnering PI option.

Second, FY15 introduced a Partnering PI Option intended for established investigators who want to pursue a more ambitious, synergistic team-based project with a higher funding level. This structure allows up to three PIs total: one Initiating PI who handles most administrative aspects of submission, plus one or more Partnering PIs. The core requirement is real synergy, not just parallel work. The proposal must show that each PI brings unique expertise that materially accelerates progress and enables outcomes that would not be achievable through separate, independent projects. Multidisciplinary and multi-institutional teams are allowed and encouraged, but they must include clear plans for coordination, communication, sharing progress and results, and transferring data. For multi-institutional efforts, the application must also include an intellectual property plan to prevent institutional barriers from undermining collaboration and to resolve potential ownership issues around inventions and materials.

From an administrative standpoint, this funding opportunity is listed as W81XWH-15-PCRP-IDA under CFDA 12.420 (Military Medical Research and Development). It is a discretionary program run through the Department of the Army, USAMRAA, and supports science and technology and other R&D activities. The opportunity anticipated 46 awards and listed an estimated total funding amount of $31.7 million, with no cost-sharing requirement. Eligibility is broadly described as unrestricted (open to any type of entity), subject to any additional clarifications in the full announcement. The posting date was May 20, 2015, with an original and current closing date of September 24, 2015, and an archive date of October 24, 2015. For access issues, the announcement directs applicants to the CDMRP Help Desk at 301-682-5507.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Rural Housing Preservation Grants

Previous opportunity: DoD Prostate Cancer Impact Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 15 PCRP IDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 15 PCRP IDA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 15 PCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.